Literature DB >> 30270207

Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerations.

Hanny Al-Samkari1, Athena Kritharis2, David J Kuter3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30270207      PMCID： PMC6165806          DOI： 10.3324/haematol.2018.203968

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients.

Authors:  Vincent Cottin; Thierry Chinet; Armelle Lavolé; Romain Corre; Eric Marchand; Martine Reynaud-Gaubert; Henri Plauchu; Jean-François Cordier
Journal:  Medicine (Baltimore)       Date:  2007-01       Impact factor: 1.889

2.  Patients with Hereditary Hemorrhagic Telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT.

Authors:  Anna Cirulli; Maria Paola Loria; Porzia Dambra; Francesca Di Serio; Maria T Ventura; Luigi Amati; Emilio Jirillo; Carlo Sabbà
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 3.  Central nervous system infections associated with hereditary hemorrhagic telangiectasia.

Authors:  O W Press; P G Ramsey
Journal:  Am J Med       Date:  1984-07       Impact factor: 4.965

Review 4.  Brain abscess and hereditary hemorrhagic telangiectasia.

Authors:  Bevin Sell; James Evans; David Horn
Journal:  South Med J       Date:  2008-06       Impact factor: 0.954

5.  Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Rafael Harpaz; Ismael R Ortega-Sanchez; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2008-06-06

Review 6.  What happened to the streptococci: overview of taxonomic and nomenclature changes.

Authors:  Richard Facklam
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 7.  Classification, identification, and clinical significance of Haemophilus and Aggregatibacter species with host specificity for humans.

Authors:  Niels Nørskov-Lauritsen
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

8.  Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response.

Authors:  Luisa Ojeda-Fernández; Lucía Recio-Poveda; Mikel Aristorena; Pedro Lastres; Francisco J Blanco; Francisco Sanz-Rodríguez; Eunate Gallardo-Vara; Mateo de las Casas-Engel; Ángel Corbí; Helen M Arthur; Carmelo Bernabeu; Luisa M Botella
Journal:  PLoS Genet       Date:  2016-03-24       Impact factor: 5.917

Review 9.  Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective.

Authors:  Athena Kritharis; Hanny Al-Samkari; David J Kuter
Journal:  Haematologica       Date:  2018-05-24       Impact factor: 9.941

10.  Cerebral Abscess Associated With Odontogenic Bacteremias, Hypoxemia, and Iron Loading in Immunocompetent Patients With Right-to-Left Shunting Through Pulmonary Arteriovenous Malformations.

Authors:  Emily J Boother; Sheila Brownlow; Hannah C Tighe; Kathleen B Bamford; James E Jackson; Claire L Shovlin
Journal:  Clin Infect Dis       Date:  2017-08-15       Impact factor: 9.079
View more
  2 in total

1.  Prevention of serious infections in hereditary hemorrhagic telangiectasia: roles for prophylactic antibiotics, the pulmonary capillaries-but not vaccination.

Authors:  Claire Shovlin; Kathleen Bamford; Carlo Sabbà; Hans-Jurgen Mager; Anette Kjeldsen; Freya Droege; Elisabetta Buscarini; Sophie Dupuis-Girod
Journal:  Haematologica       Date:  2019-02       Impact factor: 9.941

2.  Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers.

Authors:  Hanny Al-Samkari; Hasan A Albitar; Scott E Olitsky; Marianne S Clancy; Vivek N Iyer
Journal:  Orphanet J Rare Dis       Date:  2019-11-14       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.